IIRM Holdings India Limited approved the allotment of equity shares and convertible warrants worth ₹149 crore under a preferential issue on September 11, 2026.

The Board of Directors sanctioned the issuance following shareholder approval at the 33rd Annual General Meeting held on August 27, 2026. The company allotted securities to 13 out of 14 proposed offerees, with one proposed offeree, Mr. Pradeep Kumar, declining to subscribe.

Allotment Details

The issue price for both equity shares and warrants was set at ₹143.28 per unit. The transaction structure involves immediate payment for equity shares and a staggered payment model for warrants.

Each warrant entitles the holder to subscribe to one fully paid-up equity share with a face value of ₹5. Warrant holders paid an upfront amount equivalent to 25% of the issue price (₹35.82 per warrant) at the time of allotment. The remaining 75% (₹107.46 per warrant) is payable upon exercise within 18 months from the date of allotment.

Investor Participation

Carpediem Capital Partners Fund II emerged as the largest single beneficiary, receiving 11,67,295 equity shares and 66,14,671 warrants, resulting in a post-issue holding of 9.90% on a fully diluted basis. Other significant subscribers included Sanshi Fund - I (1.78% post-issue stake) and Gameplan Sports Private Limited (0.27% post-issue stake).

The remaining allottees, including Rahil Vivek Desai, Sandeep Vyas, and Anshul Kaushik, received smaller tranches ranging from 0.04% to 0.44% of the post-issue capital. All allottees are categorized as non-promoters.

What the Numbers Show

The capital raise is heavily weighted towards deferred equity conversion rather than immediate cash inflow. While the total nominal value of the issue stands at approximately ₹149 crore, the immediate cash receipt from the warrant component is limited to ₹31.66 crore (25% upfront). This structure suggests investors are leveraging the optionality of future conversion, potentially betting on share price appreciation over the 18-month exercise window before committing the full balance consideration.

IIRM Holdings India Limited received in-principle approval from the Bombay Stock Exchange on August 28, 2026, for a proposed preferential issue of equity shares and warrants to non-promoters.

The exchange approved the issuance of 15,70,352 equity shares and 88,98,657 warrants, both priced at not less than ₹143.28 per unit. Each share has a face value of ₹5. The warrants are convertible into an equal number of equity shares.

Issue Structure

The preferential allotment involves two distinct security types issued at the same price point:

The warrants will convert into 88,98,657 equity shares upon exercise. The total potential equity dilution from this transaction includes both the immediate share issuance and the future conversion of warrants.

Regulatory Compliance and Conditions

The approval was granted under Regulation 28(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company must ensure strict compliance with the Companies Act, 2013, the Securities Contracts (Regulation) Act, 1956, and the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.

BSE advised the company to strengthen internal controls to monitor trades by proposed allottees. Key requirements include:

• Obtaining undertakings from allottees confirming no intra-day trading or sales until the allotment date.
• Verifying compliance with Regulation 167(6) of the SEBI ICDR Regulations.
• Submitting a listing application within twenty days of allotment as per Schedule XIX of the ICDR Regulations.

Non-compliance with listing timelines may attract fines under SEBI circular no. SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023. The exchange reserves the right to withdraw approval if submitted information is found incomplete or misleading.